Novartis Sues Amneal, Dr. Reddy's Over Dementia Patches

By Diana Novak Jones (November 6, 2015, 8:16 PM EST) -- Novartis Pharmaceuticals Corp. and the co-owner of some of its patents filed a pair of suits in Delaware federal court Thursday over generic-drug makers Dr. Reddy's Laboratories Ltd. and Amneal Pharmaceuticals Inc.'s plans to make and market generic versions of Novartis' Exelon patch used to treat dementia associated with Parkinson's or Alzheimer's disease....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!